Literature DB >> 28794045

Pseudorabies Virus dUTPase UL50 Induces Lysosomal Degradation of Type I Interferon Receptor 1 and Antagonizes the Alpha Interferon Response.

Rui Zhang1, Aotian Xu1, Chao Qin1, Qiong Zhang2, Shifan Chen1, Yue Lang1, Mengdong Wang1, Chuang Li1, Wenhai Feng2, Rui Zhang1, Zhengfan Jiang3, Jun Tang4.   

Abstract

Alphaherpesviruses that establish persistent infections rely partly on their ability to evade host antiviral responses, notably the type I interferon (IFN) response. However, the mechanisms employed by alphaherpesviruses to avoid this response are not well understood. Pseudorabies virus (PRV) is an economically important pathogen and a useful model system for studying alphaherpesvirus biology. To identify PRV proteins that antagonize type I IFN signaling, we performed a screen by using an IFN-stimulated response element reporter in the swine cell line CRL. Unexpectedly, we identified the dUTPase UL50 as a strong inhibitor. We confirmed that UL50 has the ability to inhibit type I IFN signaling by performing ectopic expression of UL50 in cells and deletion of UL50 in PRV. Mechanistically, UL50 impeded type I IFN-induced STAT1 phosphorylation, likely by accelerating lysosomal degradation of IFN receptor 1 (IFNAR1). In addition, this UL50 activity was independent of its dUTPase activity and required amino acids 225 to 253 in the C-terminal region. The UL50 encoded by herpes simplex virus 1 (HSV-1) also possessed similar activity. Moreover, UL50-deleted PRV was more susceptible to IFN than UL50-proficient PRV. Our results suggest that in addition to its dUTPase activity, the UL50 protein of alphaherpesviruses possesses the ability to suppress type I IFN signaling by promoting lysosomal degradation of IFNAR1, thereby contributing to immune evasion. This finding reveals UL50 as a potential antiviral target.IMPORTANCE Alphaherpesviruses can establish lifelong infections and cause many diseases in humans and animals. Pseudorabies virus (PRV) is a swine alphaherpesvirus that threatens pig production. Using PRV as a model, we found that this alphaherpesvirus could utilize its encoded dUTPase UL50 to induce IFNAR1 degradation and inhibit type I IFN signaling in an enzymatic activity-independent manner. Our finding reveals a mechanism employed by an alphaherpesvirus to evade the immune response and indicates that UL50 is an important viral protein in pathogenesis and is a potential target for antiviral drug development.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  alphaherpesviruses; dUTPase UL50; interferon signaling; pseudorabies virus; type I interferon receptor 1

Mesh:

Substances:

Year:  2017        PMID: 28794045      PMCID: PMC5640830          DOI: 10.1128/JVI.01148-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Viruses and interferon: a fight for supremacy.

Authors:  Michael G Katze; Yupeng He; Michael Gale
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

2.  New genes from old: redeployment of dUTPase by herpesviruses.

Authors:  Andrew J Davison; Nigel D Stow
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Suppression of the interferon-mediated innate immune response by pseudorabies virus.

Authors:  Alla Brukman; L W Enquist
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 4.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

Review 5.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Kaposi's sarcoma-associated herpesvirus ORF54/dUTPase downregulates a ligand for the NK activating receptor NKp44.

Authors:  Alexis Spain Madrid; Don Ganem
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

7.  Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.

Authors:  Kirk J Lubick; Shelly J Robertson; Kristin L McNally; Brett A Freedman; Angela L Rasmussen; R Travis Taylor; Avram D Walts; Seitaro Tsuruda; Mizuki Sakai; Mariko Ishizuka; Elena F Boer; Erin C Foster; Abhilash I Chiramel; Conrad B Addison; Richard Green; Daniel L Kastner; Michael G Katze; Steven M Holland; Antonella Forlino; Alexandra F Freeman; Manfred Boehm; Kentaro Yoshii; Sonja M Best
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

8.  Herpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1.

Authors:  Jie Zhang; Kezhen Wang; Shuai Wang; Chunfu Zheng
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

9.  Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1.

Authors:  Dustin Verpooten; Yijie Ma; Songwang Hou; Zhipeng Yan; Bin He
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

10.  Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.

Authors:  Chuan Xia; Madhuvanthi Vijayan; Curtis J Pritzl; Serge Y Fuchs; Adrian B McDermott; Bumsuk Hahm
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

View more
  24 in total

1.  Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.

Authors:  Cuilian Yu; Aotian Xu; Yue Lang; Chao Qin; Mengdong Wang; Xiufang Yuan; Shengfu Sun; Wenhai Feng; Chao Gao; Jinwen Chen; Rui Zhang; Jun Tang
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

2.  The dUTPase of white spot syndrome virus assembles its active sites in a noncanonical manner.

Authors:  Kun Zang; Fuhua Li; Qingjun Ma
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

3.  Pseudorabies Virus Inhibits Type I and Type III Interferon-Induced Signaling via Proteasomal Degradation of Janus Kinases.

Authors:  Yue Yin; Nicolás Romero; Herman W Favoreel
Journal:  J Virol       Date:  2021-08-11       Impact factor: 5.103

4.  The dUTPase of caprine arthritis-encephalitis virus negatively regulates interferon signaling pathway.

Authors:  J Shi; X Li; M Zhu; H Chi; Y Song; J Wang; J Huang
Journal:  Iran J Vet Res       Date:  2021       Impact factor: 1.376

Review 5.  Viral dedication to vigorous destruction of interferon receptors.

Authors:  Chuan Xia; Paul Anderson; Bumsuk Hahm
Journal:  Virology       Date:  2018-07-06       Impact factor: 3.616

6.  Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity.

Authors:  Hui Yuan; Jia You; Hongjuan You; Chunfu Zheng
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

Review 7.  Host Innate Immune Response and Viral Immune Evasion During Alphaherpesvirus Infection.

Authors:  Krystal K Lum; Ileana M Cristea
Journal:  Curr Issues Mol Biol       Date:  2021-02-28       Impact factor: 2.081

Review 8.  Innate Immune Evasion of Alphaherpesvirus Tegument Proteins.

Authors:  Linjiang Yang; Mingshu Wang; Anchun Cheng; Qiao Yang; Ying Wu; Renyong Jia; Mafeng Liu; Dekang Zhu; Shun Chen; Shaqiu Zhang; Xinxin Zhao; Juan Huang; Yin Wang; Zhiwen Xu; Zhengli Chen; Ling Zhu; Qihui Luo; Yunya Liu; Yanling Yu; Ling Zhang; Bin Tian; Leichang Pan; Mujeeb Ur Rehman; Xiaoyue Chen
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

9.  PRV UL13 inhibits cGAS-STING-mediated IFN-β production by phosphorylating IRF3.

Authors:  Zongyi Bo; Yurun Miao; Rui Xi; Qiuping Zhong; Chenyi Bao; Huan Chen; Liumei Sun; Yingjuan Qian; Yong-Sam Jung; Jianjun Dai
Journal:  Vet Res       Date:  2020-09-15       Impact factor: 3.683

10.  Bclaf1 critically regulates the type I interferon response and is degraded by alphaherpesvirus US3.

Authors:  Chao Qin; Rui Zhang; Yue Lang; Anwen Shao; Aotian Xu; Wenhai Feng; Jun Han; Mengdong Wang; Wanwei He; Cuilian Yu; Jun Tang
Journal:  PLoS Pathog       Date:  2019-01-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.